Letter/Communication
Long-Term Efficacy and Safety of Luspatercept for Transfusion-Dependent β-Thalassemia
NEJM journal watch. Oncology & hematology
04/10/2025
Abstract
Luspatercept offered sustained reductions in transfusion burden and improved iron metabolism over 3+ years, with a manageable safety profile.
Details
- Title: Subtitle
- Long-Term Efficacy and Safety of Luspatercept for Transfusion-Dependent β-Thalassemia
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 04/10/2025
- Academic Unit
- Hematology/Oncology; Stead Family Department of Pediatrics
- Record Identifier
- 9984808276002771
Metrics
1 Record Views